Gena Huang

Dalian Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index189citations15works3.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(4), RNA modifications and cancer(4), Axon Guidance and Neuronal Signaling(4), Cancer, Hypoxia, and Metabolism(3), RNA Research and Splicing(2)

Publications15 total

IR-B deficiency and fatty acid dysregulation accelerate prostate cancer progression via PI3K/AKT signaling
2026Open Access
CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation
Frontiers in Genetics·2025Open Access
Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer
Diagnostic Pathology·2025Open Access
Lysosomes: guardians and healers within cells- multifaceted perspective and outlook from injury repair to disease treatment
Cancer Cell International·2025· 14 citedOpen Access
Insulin receptor alternative splicing in breast and prostate cancer
Cancer Cell International·2024· 5 citedOpen Access
Identification of differentially expressed genes-related prognostic risk model for survival prediction in breast carcinoma patients
Aging·2021· 8 citedOpen Access
Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
EBioMedicine·2020Open Access
TIAM1 Upregulation Confers NVP-BEZ235 Resistance to Breast Cancer Cells Through FGFR/STAT3 Pathway
Biochemical Genetics·2020· 9 cited
Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib
Cancer Letters·2020· 23 citedOpen Access
PRAS40 hyperexpression promotes hepatocarcinogenesis
EBioMedicine·2020· 49 citedOpen Access
RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness
Carcinogenesis·2019· 20 citedOpen Access
Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1
Biomedicine & Pharmacotherapy·2017· 41 cited
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
OncoTargets and Therapy·2017Open Access
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
OncoTargets and Therapy·2017· 8 citedOpen Access
The role of EphB4 and IGF-IR expression in breast cancer cells.
PubMed·2015· 12 citedOpen Access

Frequent Co-authors

Zuowei Zhao(4), Man Li(4), Yingjie Wu(3), Silei Sui(3), Chen Song(3), Siwen Sun(3), Man Li(3), Jingjing Qiao(3), Zhaolai Qi(2), Hongyong Fu(2), Haifeng Luo(2), Shuyun Zhao(2), Tianhua Zhang(2), Lianying Guo(2), Lingling Jin(2), Lin Huang(2), Tao Qin(2), Xuelu Li(2), Jinyu Li(2), Ning Wang(2)